Copyright © 2018 Claristock. All Right Reserved
Total Mark
88
Above 70 is preferred
Stock Analysis
| Growth Potential | 73 | |
|---|---|---|
| Profitability | 98 | |
| Financial Strength | 100 | |
| Q3 2018 Result | 97 | |
| Q2 2018 Result | 75 | |
| Result 2017 | 96 |
Growth Estimate
| 18 Estimate | 19 Estimate | |
|---|---|---|
| Revenue Growth (%) | 17.9 | 11.5 |
| EPS Growth (%) | 20.2 | 19.7 |
| ROE (%) | 63.5 | 67.6 |
| P/E (times) | ... | ... |
Market Analysis
| Market Sentiment | 97 | |
|---|---|---|
| Relative Valuation | 98 | |
| Being a Value Stock | 84 | |
| Absolute Valuation | 24 |
For more detailed information about Celgene Corporation, please go to Yahoo Finance